Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes--a preliminary study - PubMed (original) (raw)
Comparative Study
. 2012 Apr 27;37(1):111-20.
doi: 10.1016/j.pnpbp.2012.01.017. Epub 2012 Feb 7.
Affiliations
- PMID: 22343008
- DOI: 10.1016/j.pnpbp.2012.01.017
Comparative Study
Valproic acid mediates the synaptic excitatory/inhibitory balance through astrocytes--a preliminary study
Chao-Chuan Wang et al. Prog Neuropsychopharmacol Biol Psychiatry. 2012.
Abstract
Valproic acid (VPA) is one of the most widely used anticonvulsant and mood-stabilizing agents for the treatment of epilepsy and bipolar disorder. However, the underlying therapeutic mechanisms of the treatment of each disease remain unclear. Recently, the anti-epileptic effect of VPA has been found to lead to modulation of the synaptic excitatory/inhibitory balance. In addition, the therapeutic action of VPA has been linked to its effect on astrocytes by regulating gene expression at the molecular level, perhaps through an epigenetic mechanism as a histone deacetylase (HDAC) inhibitor. To provide insight into the mechanisms underlying the actions of VPA, this study investigated whether the synaptic excitatory/inhibitory (E/I) balance could be mediated by VPA through astrocytes. First, using the primary rat neuronal, astroglial, and neuro-glial mixed culture systems, we demonstrated that VPA treatment could regulate the mRNA levels of two post-synaptic cell adhesion molecules(neuroligin-1 and neuregulin-1) and two extracellular matrices (neuronal pentraxin-1and thrombospondin-3) in primary rat astrocyte cultures in a time- and concentration-dependent manner. Moreover, the up-regulation effect of VPA was noted in astrocytes, but not in neurons. In addition, these regulatory effects could be mimicked by sodium butyrate, a HDAC inhibitor, but not by lithium or two other glycogen synthase kinase-3 beta inhibitors. With the known role of these four proteins in regulating the synaptic E/I balance, we further demonstrated that VPA increased excitatory post-synaptic protein (postsynaptic density 95) and inhibitory post-synaptic protein (Gephyrin) in cortical neuro-glial mixed cultures. Our results suggested that VPA might affect the synaptic excitatory/inhibitory balance through its effect on astrocytes. This work provides the basis for future evaluation of the role of astroglial cell adhesion molecules and the extracellular matrix on the control of excitatory and inhibitory synapse formation.
Copyright © 2012 Elsevier Inc. All rights reserved.
Similar articles
- Valproic acid induces astrocyte-dependent neurite outgrowth from cultured rat primary cortical neuron via modulation of tPA/PAI-1 activity.
Cho KS, Kwon KJ, Choi CS, Jeon SJ, Kim KC, Park JH, Ko HM, Lee SH, Cheong JH, Ryu JH, Han SH, Shin CY. Cho KS, et al. Glia. 2013 May;61(5):694-709. doi: 10.1002/glia.22463. Epub 2013 Feb 4. Glia. 2013. PMID: 23378038 - Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions.
Fukuchi M, Nii T, Ishimaru N, Minamino A, Hara D, Takasaki I, Tabuchi A, Tsuda M. Fukuchi M, et al. Neurosci Res. 2009 Sep;65(1):35-43. doi: 10.1016/j.neures.2009.05.002. Epub 2009 May 20. Neurosci Res. 2009. PMID: 19463867 - Valproate protects dopaminergic neurons in midbrain neuron/glia cultures by stimulating the release of neurotrophic factors from astrocytes.
Chen PS, Peng GS, Li G, Yang S, Wu X, Wang CC, Wilson B, Lu RB, Gean PW, Chuang DM, Hong JS. Chen PS, et al. Mol Psychiatry. 2006 Dec;11(12):1116-25. doi: 10.1038/sj.mp.4001893. Epub 2006 Sep 12. Mol Psychiatry. 2006. PMID: 16969367 - Biochemical, molecular and epigenetic mechanisms of valproic acid neuroprotection.
Monti B, Polazzi E, Contestabile A. Monti B, et al. Curr Mol Pharmacol. 2009 Jan;2(1):95-109. doi: 10.2174/1874467210902010095. Curr Mol Pharmacol. 2009. PMID: 20021450 Review. - Astrocytic control of neural circuit formation: highlights on TGF-beta signaling.
Diniz LP, Matias IC, Garcia MN, Gomes FC. Diniz LP, et al. Neurochem Int. 2014 Dec;78:18-27. doi: 10.1016/j.neuint.2014.07.008. Epub 2014 Aug 11. Neurochem Int. 2014. PMID: 25125369 Review.
Cited by
- Glial pathology in bipolar disorder: potential therapeutic implications.
Dong XH, Zhen XC. Dong XH, et al. CNS Neurosci Ther. 2015 May;21(5):393-7. doi: 10.1111/cns.12390. Epub 2015 Mar 9. CNS Neurosci Ther. 2015. PMID: 25753128 Free PMC article. Review. - Human gut bacteria as potent class I histone deacetylase inhibitors in vitro through production of butyric acid and valeric acid.
Yuille S, Reichardt N, Panda S, Dunbar H, Mulder IE. Yuille S, et al. PLoS One. 2018 Jul 27;13(7):e0201073. doi: 10.1371/journal.pone.0201073. eCollection 2018. PLoS One. 2018. PMID: 30052654 Free PMC article. - Valproate-induced neurodevelopmental deficits in Xenopus laevis tadpoles.
James EJ, Gu J, Ramirez-Vizcarrondo CM, Hasan M, Truszkowski TL, Tan Y, Oupravanh PM, Khakhalin AS, Aizenman CD. James EJ, et al. J Neurosci. 2015 Feb 18;35(7):3218-29. doi: 10.1523/JNEUROSCI.4050-14.2015. J Neurosci. 2015. PMID: 25698756 Free PMC article. - N-Acetylcysteine Mitigates Social Dysfunction in a Rat Model of Autism Normalizing Glutathione Imbalance and the Altered Expression of Genes Related to Synaptic Function in Specific Brain Areas.
Schiavi S, La Rosa P, Petrillo S, Carbone E, D'Amico J, Piemonte F, Trezza V. Schiavi S, et al. Front Psychiatry. 2022 Feb 25;13:851679. doi: 10.3389/fpsyt.2022.851679. eCollection 2022. Front Psychiatry. 2022. PMID: 35280167 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources